Excited to hear this talk about Time-Restricted Diets by Dr. Grajower moderated by @theweightmd I'll try to share what I learned #AACE2022 #endotwitter What are time restricted diets? We are using intermittent fasting incorrectly -- most are actually doing time restricted eating

Let's hear The Evidence For and Against Combination #Thyroid Hormone therapy by Dr. Bianco #AACE2022 #Endotwitter. This conversation is controversial here are some of the main slides Patient's on Lt4 reporting a lot of residual symptoms in energy, cognition

Now to talk about Phosphatonins and #phosphorus metabolism/bone disease by Dr. Kumar moderated by @sfeirjad...I'm ready to learn since admittedly I know little of this #AACE2022 #Endotwitter #bone Why bother about phosphorus? Well it plays many roles in cellular signaling and maintenance of membrane structure of #bone. Low concentrations associated with rhabdo, decreased cardiac function and bone dysfunction (#osteomalacia, #rickets). low and high phos causes bone disease

Starting day 2 #AACE2022 with @ArchanaSadhu talking to us about #diabetes technologies in 2022 #endotwitter Look how far we have come in #diabetes technology and there is still a lot more to go #AACE2022. #CGM technology has been a game changer and the accuracy continues to improve with each generation

The third lecture of the series of NAFLD by Dr. Cusi - Fatty liver guru -- presenting on Current and future treatments

Diagnostic tools for diagnosis of #NAFLD and complications by Dr. Lomonaco #AACE2022 #endotwitter #NAFLD has effects on other conditions including DM, CVD, CKD etc due to increased hyperinsulinemia, insulin resistance, proinflammatory factors etc

Fantastic lecture by @scottisaacsmd on the Fatty liver epidemic and introduction to the new AACE Fatty Liver Guidelines released today. First lecture by @scottisaacsmd #AACE2022 #endotwitter NAFLD is a spectrum that includes NASH. First rule out secondary causes.

Dr. Staton discussing some therapies for #CKD and another point of view for SGLT2i benefit or risk #AACE2022 #Endotwitter #diabetes One study found that Ppl who had the largest eGFR reduction after starting ACE/ARB the slower rate of decline overall. Other study said that >10% decline had worse outcomes

Dr. Tuttle discussing diabetic CKD and benefits of relatively new med Finerenone #AACE2022 #diabetes is responsible for half of #CKD. CKD worsens CVD risk. 90% die from other cause before reaching ESRD #AACE2022 #endotwitter

Gut hormone axis. Learning from one of the best Dr. Garvey @TheAACE #aace2022 Here are the players #AACE2022 #Endotwitter

Yes looking forward to this lecture on intermittent fasting and does time of day matter. Here are types of intermittent east #AACE2021 #endotwitter Intermittent fasting definitely shows benefits in animals! #AACE2021 #endotwitter

Yes please tell me what to do with the normocalcemic hyperpara's! #aace2021 #Endotwitter In those with primary hyperparathyroidism the majority are asymptomatic. Next highest is kidney stones. It affects the radius more than fem neck more than lumbar spine #AACE2021 #Endotwitter #bone

I'm always amazed at the complexity that is obesity and insulin resistance. 2 types: obesity with insulin resistance and obesity w/o insulin resistance both will have mechanical abcd complications but the second will have dysglycemia & the effects from that #aace2021 #endotwitter Obesity exerts multisystemic effects and there is more to it then just weight and BMI -->thus the creation of the ABCD classification using info from EOSS staging system and other data #obesity #aace2021 #endotwitter

It's always a pleasure to hear Dr. Biller speak about pituitary topics. Today is on GHD. Bottom line is that there are many barriers to dx & tx esp in those who had dx as kids and are now adults but treatment can come w/ a lot of benefit #AACE2021 #Endotwitter Here are some considerations on who to test for GHD. Highest being those w/ prior pituitary/brain surgery -- if they have 3 or more pituitary deficits then it is more likely they have GHD than not. #AACE2021 #Endotwitter #ghd

Excited to learn about bariatric and metabolic surgery and newer devices by Drs. Husain and Kothari and moderated by @DrKarlNadolsky #AACE2021 Each bariatric surgery has a different expected total body weight loss with duodenal switch being highest #obesity #AACE2021 #Endotwitter

Intensive behavioral therapy by physicians can be effective helping lose >5% and even up to 10% weight loss #AACE2021 #obesity Using the term "obesity" can have a negative impact on patient care. When speaking with patients, it is better to use the terms "weight" or "BMI" or even "excess weight" #AACE2021 #obesity

When to reimage a nonfunctioning pituitary incidentaloma? Risk of growth depends on size. Dr. Molitch recommends <1cm repeat MRI 1, 2, 5yrs. >1cm 0.5, 1, 2, 5yrs #ENDO2021 #Endotwitter What about symptomatic nonfunctioning pituitary adenomas? Depends on surgery outcome #ENDO2021 #Endotwitter

Learning about Omnipod 5 the first tubeless automated pump - users will be able to control pump through their phone! Adjustable targets and bolus calculator uses glucose trends to make recs for bolus! #diabetes #ENDO2021 #Endotwitter Omnipod 5 adult trials recruited overall well controlled diabetics but were still able to improve TIR with minimal TBR seen in all age groups. #diabetes #ENDO2021 #Endotwitter

No drug holiday with denosumab b/c even if giving zoledronate after there is still a loss of BMD #ENDO2021 #Endotwitter Good slide I will be adding to my resource folder to help remember fracture data for each osteoporosis med #ENDO2021 #Endotwitter

DKA at diagnosis was significantly associated with worse memory and longterm DM control #ENDO2021 #Endotwitter #diabetes Residual beta cell function to avoid symptomatic T1D is >25% #ENDO2021 #Endotwitter #diabetes